Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
DENMARK — Danish pharmaceutical company Novo Nordisk is set to invest 5.4 billion Danish kroner (US$743.6 million) in expanding its facilities in Bagsvaerd, Denmark, which will include construction of a…
Read More
DENMARK — Novo Nordisk has signed a collaboration agreement with Biocorp for the initial commercialization of Mallya, initially in Japan. Mallya connects directly to Novo Nordisk FlexTouch insulin pens, allowing…
Read More
DENMARK – Novo Nordisk has published topline results from six Phase 3a clinical trials in the ONWARDS program of once-weekly insulin icodec in diabetics. Insulin icodec is a novel once-weekly…
Read More
DENMARK – Denmark’s Novo Nordisk Foundation has pledged US$200 million (£176m) to develop what it says will be the first quantum computer dedicated to life sciences research and the green…
Read More
DENMARK – Nine ventures and two projects have become the latest addition to the BioInnovation Institute’s (BII) Venture Lab acceleration program for early-stage companies. BII is an international commercial non-profit…
Read More
DENMARK- Novo Nordisk has entered into a legally binding agreement to acquire clinical-stage biopharmaceutical firm Forma Therapeutics in a deal valued at US$1.1 billion (or US$20 per share). Forma Therapeutics…
Read More
UGANDA – Uganda has received three generators worth UGX571,220,522 (US$154,537) from the World Health Organization (WHO) to ensure steady supply of power for the oxygen plants and medical response in…
Read More
DENMARK – According to a Danish study, the omicron BA.2 subvariant is inherently more contagious and more capable of infecting vaccinated people than any other Covid strain, but vaccinated people…
Read More
DENMARK – The European Commission has granted marketing authorization of Lundbeck’s anti-Calcitonin Gene Related Protein (Anti-CGRP) antibody Vyepti (eptinezumab) in the European Union (EU) for the prophylactic treatment of migraine…
Read More
DENMARK – Novozymes and Novo Nordisk Pharmatech have announced a collaboration agreement that brings together the companies’ shared competencies and interests in the development of specialty enzymes for use in…
Read More